Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/180532
Title: Telemedicine Strategy to Rescue CPAP Therapy in Sleep Apnea Patients with Low Treatment Adherence: A Pilot Study
Author: Garmendia, Onintza
Farré, Ramon
Ruiz, Concepción
Suarez Girón, Monique
Torres, Marta
Cebrian, Raisa
Saura, Laura
Monasterio, Carmen
Negrín, Miguel A.
Montserrat, Josep M.
Keywords: Síndromes d'apnea del son
Salut en línia
Cura dels malalts
Sleep apnea syndromes
Medical telematics
Care of the sick
Issue Date: 13-Sep-2021
Publisher: MDPI AG
Abstract: Patients with sleep apnea are usually treated with continuous positive airway pressure (CPAP). This therapy is very effective if the patient's adherence is satisfactory. However, although CPAP adherence is usually acceptable during the first months of therapy, it progressively decreases, with a considerable number of patients accepting average treatment duration below the effectiveness threshold (4 h/night). Herein, our aim was to describe and evaluate a novel telemedicine strategy for rescuing CPAP treatment in patients with low adherence after several months/years of treatment. This two-week intervention includes (1) patient support using a smartphone application, phone and voice recorder messages to be answered by a nurse, and (2) daily transmission and analysis of signals from the CPAP device and potential variation of nasal pressure if required. On average, at the end of the intervention, median CPAP adherence considerably increased by 2.17 h/night (from 3.07 to 5.24 h/night). Interestingly, the procedure was able to markedly rescue CPAP adherence: the number of patients with poor adherence (<4 h/night) was considerably reduced from 38 to 7. After one month, adherence improvement was maintained (median 5.09 h/night), and only 13 patients had poor adherence (<4 h/night). This telemedicine intervention (103€ per included patient) is a cost-effective tool for substantially increasing the number of patients with CPAP adherence above the minimum threshold for achieving positive therapeutic effects.
Note: Reproducció del document publicat a: https://doi.org/10.3390/jcm10184123
It is part of: Journal of Clinical Medicine, 2021, vol. 10, num. 18, p. 4123
URI: http://hdl.handle.net/2445/180532
Related resource: https://doi.org/10.3390/jcm10184123
ISSN: 2077-0383
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
jcm-10-04123.pdf2 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons